CB1cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

Signal Transduction via Cannabinoid Receptors

(2012) George Dalton et al.   CNS & Neurological Disorders-Drug Targets

Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro

(2009) Partha Mukhopadhyay et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction

(2009) Shiang Y. Lim et al.   BASIC RESEARCH IN CARDIOLOGY

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

(2009) Roger G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages

(2009) K. H. Han et al.   CARDIOVASCULAR RESEARCH

CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes

(2009) Partha Mukhopadhyay et al.   CARDIOVASCULAR RESEARCH

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy

(2009) Partha Mukhopadhyay et al.   FREE RADICAL BIOLOGY AND MEDICINE

Role of peroxynitrite in the redox regulation of cell signal transduction pathways

(2009) Lucas Liaudet   Frontiers in Bioscience-Landmark

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia

(2009) P. Caraceni et al.   GUT

Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon

(2009) Antonietta Santoro et al.   INTERNATIONAL JOURNAL OF CANCER

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

(2009) Ming Zhang et al.   Journal of Neuroimmune Pharmacology

End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion

(2009) Maurizio Bifulco et al.   NATURE REVIEWS DRUG DISCOVERY

Endocannabinoid system modulation in cancer biology and therapy

(2009) Simona Pisanti et al.   PHARMACOLOGICAL RESEARCH

The emerging role of the endocannabinoid system in cardiovascular disease

(2009) Pál Pacher et al.   Seminars in Immunopathology

CENTRAL CANNABINOID 1 RECEPTOR ANTAGONIST ADMINISTRATION PREVENTS ENDOTOXIC HYPOTENSION AFFECTING NOREPINEPHRINE RELEASE IN THE PREOPTIC ANTERIOR HYPOTHALAMIC AREA

(2009) Alex Villanueva et al.   SHOCK

Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases

(2008) Pál Pacher et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

(2008) Frédérique Dol-Gleizes et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cannabinoid CB 1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders

(2008) Pál Pacher   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats

(2008) A Schäfer et al.   BRITISH JOURNAL OF PHARMACOLOGY

Guide to Receptors and Channels (GRAC), 3rd edition

(2008) S P H Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages

(2008) Koichi Sugamura et al.   CIRCULATION

Modulation of the Endocannabinoid System in Cardiovascular Disease

(2008) Pál Pacher et al.   HYPERTENSION

Dysregulation of the Endocannabinoid System in Obesity

(2008) S. Engeli   JOURNAL OF NEUROENDOCRINOLOGY

Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death

(2008) H. Pan et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

(2008) N. Pabla et al.   KIDNEY INTERNATIONAL

Targeting the endocannabinoid system: to enhance or reduce?

(2008) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

CB2 receptors as new therapeutic targets for liver diseases

(2007) S Lotersztajn et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning

(2007) P Pacher et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoid receptors in acute and chronic complications of atherosclerosis

(2007) F Mach et al.   BRITISH JOURNAL OF PHARMACOLOGY

Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells

(2007) A M Malfitano et al.   BRITISH JOURNAL OF PHARMACOLOGY

Multiple pathways involved in the biosynthesis of anandamide

(2007) Jie Liu et al.   NEUROPHARMACOLOGY

Selective iNOS inhibition reduces renal damage induced by cisplatin

(2007) Yolanda I. Chirino et al.   TOXICOLOGY LETTERS

Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well?

(2006) Péter Ferdinandy   BRITISH JOURNAL OF PHARMACOLOGY